CX-2051
CTMX-2051-101
Phase 1 small_molecule active
Quick answer
CX-2051 for Solid Tumor, Adult is a Phase 1 program (small_molecule) at CytomX Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CytomX Therapeutics
- Indication
- Solid Tumor, Adult
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active